Price $115.75 |
Market Cap
9.45B
|
Sector Health Care |
Div. Growth
10.70%
|
|
P/E
33.7
|
P/B
3.07
|
P/S
3.57
|
Dividend %
1.20%
|
|
P/CF
-
|
P/FCF
44.4
|
Op. Cash Flow
477.8K
|
FCF
2.5
|
|
Op. Margin
15.50%
|
Net Margin
11.40%
|
ROE
9.70%
|
ROI
7.10%
|
|
ROA
5.90%
|
EPS Growth
154.30%
|
Current Ratio
2.5
|
Debt/Equity
41.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.19 | - | - | 40.1M | Strong Buy |
| Integer Holdings Corp (ITGR) | $83.10 | - | - | 2.7B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.49 | - | - | 61.1M | Strong Buy |
| Correvio Pharma Corp (CORV) | $3.30 | - | - | 122.4M | Strong Buy |
| RTI Surgical Inc (RTIX) | $4.29 | - | - | 289.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
